# OBPM\_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

Study · id `cardio:ct-nct07507903` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07507903](<https://clinicaltrials.gov/study/NCT07507903>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07507903

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07507903. Allocation not applicable; no masking; primary purpose other. Start 2026-04-14 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07507903, source copy `cardio:ctgov-nct07507903-2026-09-14`, retrieved 2026-10-26)
- Started: 2026-04-14 (actual) (ClinicalTrials.gov record NCT07507903, source copy `cardio:ctgov-nct07507903-2026-09-14`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT07507903, source copy `cardio:ctgov-nct07507903-2026-09-14`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT07507903, source copy `cardio:ctgov-nct07507903-2026-09-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07507903, source copy `cardio:ctgov-nct07507903-2026-09-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07507903-2026-09-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: OBPM\_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device
- Acronym: OBPM\_PANDA2026
- Condition: Hypertension
- Intervention (Device): Device under test evaluation against references
- Lead sponsor: Aktiia SA
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Aktiia SA (`cardio:org-aktiia-sa`)

## Provenance

Content hash: 8d6e03f195147ac5ac8bb1e9ac1e787788194219b1c3a13545d3fd8d78cf12d4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
